NanoViricides
NNVC
$1.10
Share price
-0.90%
Change (1 day)
-17.29%
Change (1 year)
Categories
NanoViricides (NNVC) - P/B ratio
P/B ratio as of April 2024 : 1.04
According to NanoViricides's latest financial reports the company has a price-to-book ratio of 1.04.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
NanoViricides - P/B ratio (from 2007 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.9622 | 48.37% |
| 2022-12-31 | 0.6486 | -59.96% |
| 2021-12-31 | 1.62 | 46.85% |
| 2020-12-31 | 1.10 | -12.31% |
| 2019-12-31 | 1.26 | 25.26% |
| 2018-12-31 | 1.00 | -71.32% |
| 2017-12-31 | 3.50 | 7.65% |
| 2016-12-31 | 3.25 | 35.32% |
| 2015-12-31 | 2.40 | -52.33% |
| 2014-12-31 | 5.04 | -78.56% |
| 2013-12-31 | 23.5 | 346.92% |
| 2012-12-31 | 5.26 | -28.42% |
| 2011-12-31 | 7.35 | -66.24% |
| 2010-12-31 | 21.8 | -15.53% |
| 2009-12-31 | 25.8 | -33.02% |
| 2008-12-31 | 38.5 | 75.61% |
| 2007-12-31 | 21.9 | |
| 2006-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | 3.59 | 244.60% | 🇺🇸 USA |
 Merck MRK | 8.83 | 748.57% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 3.08 | 196.26% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 5.16 | 395.52% | 🇬🇧 UK |
 Novavax NVAX | -0.7984 | -176.73% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | -1.88 | -280.91% | 🇺🇸 USA |